Disease and Therapeutics
Издатель: Elsevier · ISSN 3050-9998 · 20 статей
- ProxiCapture reveals context-dependent CRBN interactome landscape of molecular glue degraders
- CLIP-LUX: A luminescent split-ubiquitin assay using ClpS-mediated N-degron recognition for detection of protein-protein interactions in mammalian cells
- A tetravalent PD-L1/VEGF bispecific antibody blocks tumor growth In Vivo
- TBLncDB: A comprehensive lncRNA database for tuberculosis therapeutics and biomarker discovery
- Psychomotor disturbance as a predictor of treatment response in mood disorders: A systematic review
- Disruption of myocardial NAD⁺ balance in heart failure: Mechanisms and therapeutic opportunities
- Non-small cell lung cancer in 2026: A narrative review of clinical advances and systemic challenges
- Chronic and emerging immune-related adverse events from immune checkpoint inhibitors
- Next-generation CAR-T combinations: Integrating nanomedicine, metabolic reprogramming, and AI for solid tumor targeting
- Postoperative prophylactic corticotropin-releasing hormone receptor 1 (CRHR1) antagonism attenuates post-surgical peritoneal adhesion formation in a rat cecal abrasion model
- Title: A CXCR2-specific monoclonal antibody alleviates excessive neutrophil syndromes in preclinical models of inflammation
- Biomimetic internalin B-engineered liposomes enable PROTAC delivery across endothelial barriers
- Multi-target mechanisms of ginger constituents against osteoarthritis based on food-medicine homology: An integrative network pharmacology, molecular docking and molecular dynamics study
- Next generation medicines: Emerging approaches to drug ‘difficult to drug’ targets
- Translational control as a driver of tumor plasticity, metastasis, and therapeutic resistance in triple-negative breast cancer
- Perturbations at scale: Transforming our understanding of cell biology by changing the genome
- Artificial intelligence in the pharmaceutical research and development lifecycle: Applications, ethical challenges, and governance considerations
- Yeast split intein-mediated protein ligation (ySIMPL) system for detecting protein-protein interactions of mechanosensory proteins
- KRAS Q61H drives acquired resistance to toceranib through sustained RAS–MAPK signaling in canine mast cell tumor cells
- Tumor-homing Bispecific Antibodies that Co-engage EPHA2 and Frizzled Receptors Target RNF43-mutant Pancreatic Cancer and Minimize Toxicity